Mert Duman is the Chief Executive Officer of AdRegeneer, bringing deep expertise in neuroscience and years of postdoctoral experience from leading institutions, including the University of Fribourg, the University of Bern, and Johannes Gutenberg University Mainz. His research has focused on neurodegenerative diseases and the biology of nervous system myelination. With his scientific insight and strategic vision, Mert drives AdRegeneer’s mission to develop innovative therapies that restore neural function and improve patients’ lives.